Treatment indications informed by a
View Patent ↗Systems and methods are described for implementing or deploying therapeutic administration systems for obtaining a flow-change-indicative measurement and signaling a decision whether to administer one or more clot-reducing agents at least partly based on the flow-change-indicative measurement.
1. A therapeutic administration system comprising:
one or more modules for obtaining a flow-change indicative measurement;
one or more modules for signaling a decision whether to administer one or more clot-reducing agents at least partly based on the flow-change-indicative measurement;
a first dispenser operable for dispensing at least a lytic material;
a second dispenser operable for targeting an implant site; and
a wireless-communication device operable for communicating a selection of the first dispenser or the second dispenser.
2. The therapeutic administration system of claim 1 in which the one or more modules for obtaining a flow-change-indicative measurement comprise:
a module for programming an implantable device.
3. The therapeutic administration system of claim 1 in which the one or more modules for obtaining a flow-change-indicative measurement comprise:
a turbulence-indicative auditory valve as the flow-change-indicative measurement.
4. The therapeutic administration system of claim 1 in which the one or more modules for obtaining a flow-change-indicative measurement comprise:
a module for detecting one or more conditions optically.
5. The therapeutic administration system of claim 4 in which the one or more modules for obtaining a flow-change-indicative measurement comprise:
a turbulence-indicative auditory value as the flow-change-indicative measurement.
6. The therapeutic administration system of claim 1 in which the one or more modules for obtaining a flow-change-indicative measurement comprise:
a module for detecting one or more force-change-indicative values.
7. The therapeutic administration system of claim 6 in which the one or more modules for signaling a decision whether to administer one or more clot-reducing agents at least partly based on the flow-change-indicative measurement comprise:
a module for causing one or more dispensations in response to an apparent problem in the flow-change-indicative measurement.
8. The therapeutic administration system of claim 6 , further comprising:
a thrombolytic-agent-containing dispenser responsive to the decision whether to administer the one or more clot-reducing agents.
9. The therapeutic administration system of claim 1 in which the one or more modules for signaling a decision whether to administer one or more clot-reducing agents at least partly based on the flow-change-indicative measurement comprise:
a module for deciding upon at least one of the one or more clot-reducing agents in response to obtaining an anomalous value as the flow-change-indicative measurement.
10. The therapeutic administration system of claim 1 in which the one or more modules for signaling a decision whether to administer one or more clot-reducing agents at least partly based on the flow-change-indicative measurement comprise:
a module for signaling at least an anticoagulant of the one or more clot-reducing agents in response to an apparent flow degradation.
11. The therapeutic administration system of claim 10 in which the one or more modules for signaling a decision whether to administer one or more clot-reducing agents at least partly based on the flow-change-indicative measurement comprise:
a module for one or more dispensations in response to an apparent problem in the flow-change-indicative measurement.
12. The therapeutic administration system of claim 1 in which one or more modules for signaling a decision whether to administer one or more clot-reducing agents at least partly based on the flow-change-indicative measurement comprise:
one or more instructions responsive to a flow-force-responsive element.
13. The therapeutic administration system of claim 1 in which the one or more modules for signaling a decision whether to administer one or more clot-reducing agents at least partly based on the flow-change-indicative measurement comprise:
one or more instructions responsive to an optical sensor.
14. The therapeutic administration system of claim 13 , further comprising:
a thrombolytic-agent-containing dispenser responsive to the decision whether to administer the one or more clot-reducing agents.
15. The therapeutic administration system of claim 1 in which the one or more modules for signaling a decision whether to administer one or more clot-reducing agents at least partly based on the flow-change-indicative measurement comprise:
one or more instructions responsive to an auditory sensor.
16. The therapeutic administration system of claim 1 in which the one or more modules for signaling a decision whether to administer one or more clot-reducing agents at least partly based on the flow-change-indicative measurement comprise:
a module for causing one or more dispensations in response to an apparent problem in the flow-change-indicative measurement.
17. The therapeutic administration system of claim 1 , further comprising:
a thrombolytic-agent-containing dispenser responsive to the decision whether to administer the one or more clot-reducing agents.
18. The therapeutic administration system of claim 1 , further comprising:
an implant-site-targeting dispenser responsive to the decision whether to administer the one or more clot-reducing agents.
19. The therapeutic administration system of claim 1 in which the one or more modules for signaling a decision whether to administer one or more clot-reducing agents at least partly based on the flow-change-indicative measurement comprise:
a module for signaling at least an anticoagulant of the one or more clot-reducing agents in response to an apparent flow degradation.
20. A therapeutic administration system comprising:
one or more modules for obtaining a flow-change-indicative measurement;
one or more modules for signaling a decision whether to administer one or more clot-reducing agents at least partly based on the flow-change-indicative measurement;
a first dispenser operable for dispensing at least a clot-reducing agent;
a second dispenser operable for targeting an implant site; and
a wireless-communication device operable for communicating a selection of the first dispenser or the second dispenser.
21. A therapeutic administration method comprising:
obtaining a flow-change-indicative measurement;
signaling a decision whether to administer one or more clot-reducing agents at least partly based on the flow-change-indicative measurement;
dispensing, from a first dispenser, at least a lytic material;
targeting, utilizing a second dispenser, an implant site and
communicating, using a wireless-communication device, a selection of the first dispenser or the second dispenser.